Overview
BiOkuris develops next-generation medical nutrition products tailored to unmet medical needs of patients with chronic intestinal diseases such as IBS, IBD, and Candidiasis. The company's solutions are designed to improve physiopathology and quality of life for patients with these conditions. The company announced positive results from a pivotal IBS study evaluating BK002.
In the news
- De Waalse kampioenen ». C’est la série d’articles que le journal De Standaard entame avec KitOzyme comme premier « champion ». Une très belle occasion de faire ainsi mieux connaître la biotech « Made in Wallonië » dans notre propre pays. … Une belle ouverture d’esprit ! Et l’occasion de se réjouir de l’initiative. Bravo ! De Standaard Giselle Nath (PhD) bio.be KitOzyme KiOmed Pharma BiOkuris
- Living with digestive discomfort is more than just a physical burden, it can significantly affect quality of life. Discomfort, unpredictability, and emotional strain make everyday routines difficult for many individuals. Yet most solutions focus on individual symptoms rather than the broader impact on well-being. BK005 was developed with this broader patient experience in mind, providing digestive support while improving overall well-being. 🔬Proprietary solution combining: - Chitin-glucan (Biokuris proprietary
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.